[Hematopoietic cell transplantation for monogenic inflammatory bowel disease]

Rinsho Ketsueki. 2023;64(9):1213-1221. doi: 10.11406/rinketsu.64.1213.
[Article in Japanese]

Abstract

The pathogenesis of inflammatory bowel disease (IBD) may include immune dysregulation. About 20% of inborn errors of immunity (IEIs) are related to IBD, and more than 60 IEIs are known to present IBD. Monogenic IBDs include those that are refractory to traditional treatment and can be cured by allogeneic hematopoietic cell transplantation (HCT), making early diagnosis and treatment essential. In this report, we present a series of monogenic IBDs that are relatively frequently found in Japan, such as interleukin (IL)-10/IL-10 receptor deficiency, chronic granulomatous disease, XIAP deficiency, immunodysregulation, polyendocrinopathy, enteropathy, and X-linked (IPEX) syndrome, NEMO deficiency, and A20 haploinsufficiency and will describe the features of each IEI and the indications for HCT.

Keywords: Hematopoietic cell transplantation; Inborn errors of immunity; Inflammatory bowel disease; X-linked inhibitor of apoptosis.

Publication types

  • English Abstract

MeSH terms

  • Genetic Diseases, X-Linked* / therapy
  • Granulomatous Disease, Chronic*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Inflammatory Bowel Diseases* / diagnosis
  • Inflammatory Bowel Diseases* / genetics
  • Inflammatory Bowel Diseases* / therapy

Supplementary concepts

  • Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome